| Maternal education and child mortality in Zimbabwe KA Grépin, P Bharadwaj Journal of health economics 44, 97-117, 2015 | 237 | 2015 |
| Women are most affected by pandemics—lessons from past outbreaks C Wenham, J Smith, SE Davies, H Feng, KA Grépin, S Harman, ... Nature 583 (7815), 194-198, 2020 | 193 | 2020 |
| HIV donor funding has both boosted and curbed the delivery of different non-HIV health services in sub-Saharan Africa KA Grépin Health affairs 31 (7), 1406-1414, 2012 | 98 | 2012 |
| Approaches and alternatives to the wealth index to measure socioeconomic status using survey data: a critical interpretive synthesis MJP Poirier, KA Grépin, M Grignon Social Indicators Research 148 (1), 1-46, 2020 | 93 | 2020 |
| Approaches and Alternatives to the Wealth Index to Measure Socioeconomic Status Using Survey Data: A Critical Interpretive Synthesis MG Mathieu J. P. Poirier, Karen A. Grépin Social Indicators Research, 2019 | 93* | 2019 |
| Global coordination on cross-border travel and trade measures crucial to COVID-19 response K Lee, CZ Worsnop, KA Grépin, A Kamradt-Scott The Lancet 395 (10237), 1593-1595, 2020 | 86 | 2020 |
| Patterns of demand for non-Ebola health services during and after the Ebola outbreak: panel survey evidence from Monrovia, Liberia B Morse, KA Grépin, RA Blair, L Tsai BMJ Global Health 1, e000007, 2016 | 85 | 2016 |
| China’s role as a global health donor in Africa: what can we learn from studying under reported resource flows? KA Grépin, VY Fan, GC Shen, L Chen Globalization and health 10 (1), 1-11, 2014 | 79 | 2014 |
| Evidence of the effectiveness of travel-related measures during the early phase of the COVID-19 pandemic: a rapid systematic review KA Grépin, TL Ho, Z Liu, S Marion, J Piper, CZ Worsnop, K Lee BMJ global health 6 (3), e004537, 2021 | 77 | 2021 |
| Conceptualizing integration: a framework for analysis applied to neglected tropical disease control partnerships KA Grepin, MR Reich PLoS Neglected Tropical Diseases 2 (4), e174, 2008 | 77 | 2008 |
| Private sector an important but not dominant provider of key health services in low-and middle-income countries KA Grépin Health Affairs 35 (7), 1214-1221, 2016 | 65 | 2016 |
| Longitudinal assessment of changes in HIV-specific effector activity in HIV-infected patients starting highly active antiretroviral therapy in primary infection G Alter, G Hatzakis, CM Tsoukas, K Pelley, D Rouleau, R LeBlanc, ... The Journal of Immunology 171 (1), 477-488, 2003 | 56 | 2003 |
| More than a public health crisis: A feminist political economic analysis of COVID-19 J Smith, SE Davies, H Feng, CCR Gan, KA Grépin, S Harman, ... Global Public Health 16 (8-9), 1364-1380, 2021 | 55 | 2021 |
| The impact of an mHealth monitoring system on health care utilization by mothers and children: an evaluation using routine health information in Rwanda H Ruton, A Musabyimana, E Gaju, A Berhe, KA Grépin, J Ngenzi, ... Health policy and planning 33 (8), 920-927, 2018 | 52 | 2018 |
| The impact of incremental innovation in biopharmaceuticals: drug utilisation in original and supplemental indications ER Berndt, IM Cockburn, KA Grepin Pharmacoeconomics 24, 69-86, 2006 | 50 | 2006 |
| Limited early warnings and public attention to coronavirus disease 2019 in China, January–February, 2020: a longitudinal cohort of randomly sampled Weibo users Y Zhu, KW Fu, KA Grépin, H Liang, ICH Fung Disaster medicine and public health preparedness 14 (5), e24-e27, 2020 | 48 | 2020 |
| International donations to the Ebola virus outbreak: too little, too late? KA Grépin Bmj 350, 2015 | 47 | 2015 |
| Disruptions in maternal health service use during the COVID-19 pandemic in 2020: experiences from 37 health facilities in low-income and middle-income countries Z Aranda, T Binde, K Tashman, A Tadikonda, B Mawindo, D Maweu, ... BMJ global health 7 (1), e007247, 2022 | 46 | 2022 |
| How to do (or not to do)… Tracking data on development assistance for health KA Grépin, K Leach-Kemon, M Schneider, D Sridhar Health policy and planning 27 (6), 527-534, 2012 | 46 | 2012 |
| Donor funding health policy and systems research in low-and middle-income countries: how much, from where and to whom KA Grépin, CB Pinkstaff, ZC Shroff, A Ghaffar Health research policy and systems 15 (1), 1-8, 2017 | 44 | 2017 |
Michael LawCanada Research Chair in Access to Medicines, University of British ColumbiaVerified email at ubc.ca
